Copy number variation and autism: New insights and clinical implications

Journal of the Formosan Medical Association

Volumn 113, Issue 7, 2014, Pages 400-408

  Chung, Brian Hon Yin ^a,b   Tao, Victoria Qinchen ^a   Tso, Winnie Wan Yee ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Autism spectrum disorder; Chromosome microarray; Copy number variation; Genetic counseling; Genetic testing

Indexed keywords

AUTISM; COPY NUMBER VARIATION; CYTOGENETICS; EVIDENCE BASED PRACTICE; GENETIC COUNSELING; HUMAN; HUMAN GENOME; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); DNA MICROARRAY; GENETIC SCREENING; GENETICS; INTERPERSONAL COMMUNICATION; PHYSICIAN ATTITUDE;

CHILD DEVELOPMENT DISORDERS, PERVASIVE; DNA COPY NUMBER VARIATIONS; GENETIC COUNSELING; GENETIC TESTING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHYSICIAN'S ROLE; TRUTH DISCLOSURE;

EID: 84902829299     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2013.01.005     Document Type: Review

References (84)

1. Autism and Developmental Disabilities Monitoring Network. Prevalence of autism spectrum disorders (ASDs) among multiple areas of the United States in 2008. Community Report From the Autism and Developmental Disabilities Monitoring (ADDM) Network. National Center on Birth Defects and Developmental Disabilities; Centers for Disease Control and Prevention. Atlanta, GA. 2012.
2. Mefford H.C., Batshaw M.L., Hoffman E.P. Genomics, intellectual disability, and autism. N Engl J Med 2012, 366:733-743.
3. A 05 autism spectrum disorder 2011, American Psychiatric Association (APA), APA, Arlington, Avaliable at:, [accessed 09.07.12]. http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx%3frid%3d94#.
4. Spezio M.L., Adolphs R., Hurley R.S., Piven J. Analysis of face gaze in autism using "Bubbles". Neuropsychologia 2007, 45:144-151.
5. Craig M.C., Zaman S.H., Daly E.M., Cutter W.J., Robertson D.M., Hallahan B., et al. Women with autistic-spectrum disorder: magnetic resonance imaging study of brain anatomy. Br J Psychiatry 2007, 191:224-228.
6. Dinstein I., Pierce K., Eyler L., Solso S., Malach R., Behrmann M., et al. Disrupted neural synchronization in toddlers with autism. Neuron 2011, 70:1218-1225.
7. Chakrabarti S., Fombonne E. Pervasive developmental disorders in preschool children. JAMA 2001, 285:3093-3099.
8. Folstein S.E., Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2001, 2:943-955.
9. Ozonoff S., Young G.S., Carter A., Messinger D., Yirmiya N., Zwaigenbaum L., et al. Recurrence risk for autism spectrum disorders: a baby siblings research consortium study. Pediatrics 2011, 128:e488-e495.
10. Coe B.P., Girirajan S., Eichler E.E. The genetic variability and commonality of neurodevelopmental disease. Am J Med Genet C Semin Med Genet 2012, 160C:118-129.
11. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 2011, 1380:42-77.
12. Marshall C.R., Scherer S.W. Detection and characterization of copy number variation in autism spectrum disorder. Methods Mol Biol 2012, 838:115-135.
13. Gau S.S., Liao H.M., Hong C.C., Chien W.H., Chen C.H. Identification of two inherited copy number variants in a male with autism supports two-hit and compound heterozygosity models of autism. Am J Med Genet B Neuropsychiatr Genet 2012, 159B:710-717.
14. Chien W.H., Gau S.S., Wu Y.Y., Huang Y.S., Fang J.S., Chen Y.J., et al. Identification and molecular characterization of two novel chromosomal deletions associated with autism. Clin Genet 2010, 78:449-456.
15. Feuk L., Carson A.R., Scherer S.W. Structural variation in the human genome. Nat Rev Genet 2006, 7:85-97.
16. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., et al. Global variation in copy number in the human genome. Nature 2006, 444:444-454.
17. Iafrate A.J., Feuk L., Rivera M.N., Listewnik M.L., Donahoe P.K., Qi Y., et al. Detection of large-scale variation in the human genome. Nat Genet 2004, 36:949-951.
18. Sebat J., Lakshmi B., Troge J., Alexander J., Young J., Lundin P., et al. Large-scale copy number polymorphism in the human genome. Science 2004, 305:525-528.
19. Cook E.H., Scherer S.W. Copy-number variations associated with neuropsychiatric conditions. Nature 2008, 455:919-923.
20. Lupski J.R. Genomic rearrangements and sporadic disease. Nat Genet 2007, 39:S43-S47.
21. Stankiewicz P., Lupski J.R. Genome architecture, rearrangements and genomic disorders. Trends Genet 2002, 18:74-82.
22. Xu J., Zwaigenbaum L., Szatmari P., Scherer S.W. Molecular cytogenetics of autism. Curr Genomics 2004, 5:347-364.
23. Zahir F., Friedman J.M. The impact of array genomic hybridization on mental retardation research: a review of current technologies and their clinical utility. Clin Genet 2007, 72:271-287.
24. Connolly J.J., Hakonarson H. The impact of genomics on pediatric research and medicine. Pediatrics 2012, 129:1150-1160.
25. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., et al. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
26. Marshall C.R., Noor A., Vincent J.B., Lionel A.C., Feuk L., Skaug J., et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008, 82:477-488.
27. Szatmari P., Paterson A.D., Zwaigenbaum L., Roberts W., Brian J., et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007, 39:319-328. Autism Genome Project Consortium.
28. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008, 358:667-675.
29. Kumar R.A., KaraMohamed S., Sudi J., Conrad D.F., Brune C., Badner J.A., et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008, 17:628-638.
30. Christian S.L., Brune C.W., Sudi J., Kumar R.A., Liu S., Karamohamed S., et al. Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol Psychiatry 2008, 63:1111-1117.
31. Jacquemont M.L., Sanlaville D., Redon R., Raoul O., Cormier-Daire V., Lyonnet S., et al. Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet 2006, 43:843-849.
32. Morrow E.M., Yoo S.Y., Flavell S.W., Kim T.K., Lin Y., Hill R.S., et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008, 321:218-223.
33. Glessner J.T., Wang K., Cai G., Korvatska O., Kim C.E., Wood S., et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009, 459:569-573.
34. de Kovel C.G., Trucks H., Helbig I., Mefford H.C., Baker C., Leu C., et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 2010, 133:23-32.
35. Girirajan S., Rosenfeld J.A., Cooper G.M., Antonacci F., Siswara P., Itsara A., et al. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 2010, 42:203-209.
36. Leblond C.S., Heinrich J., Delorme R., Proepper C., Betancur C., Huguet G., et al. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 2012, 8:e1002521.
37. Hu-Lince D., Craig D.W., Huentelman M.J., Stephan D.A. The Autism Genome Project: goals and strategies. Am J Pharmacogenomics 2005, 5:233-246.
38. Pinto D., Pagnamenta A.T., Klei L., Anney R., Merico D., Regan R., et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466:368-372.
39. Fischbach G.D., Lord C. The Simons Simplex Collection: a resource for identification of autism genetic risk factors. Neuron 2010, 68:192-195.
40. Sanders S.J., Ercan-Sencicek A.G., Hus V., Luo R., Murtha M.T., Moreno-De-Luca D., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70:863-885.
41. Devlin B., Scherer S.W. Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev 2012, 22:229-237.
42. Sisodiya S.M., Mefford H.C. Genetic contribution to common epilepsies. Curr Opin Neurol 2011, 24:140-145.
43. Stefansson H., Rujescu D., Cichon S., Pietiläinen O.P., Ingason A., Steinberg S., et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455:232-236.
44. Liao H.M., Chao Y.L., Huang A.L., Cheng M.C., Chen Y.J., Lee K.F., et al. Identification and characterization of three inherited genomic copy number variations associated with familial schizophrenia. Schizophr Res 2012, 139:229-236.
45. Berkel S., Marshall C.R., Weiss B., Howe J., Roeth R., Moog U., et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 2010, 42:489-491.
46. Sykes N.H., Toma C., Wilson N., Volpi E.V., Sousa I., Pagnamenta A.T., et al. Copy number variation and association analysis of SHANK3 as a candidate gene for autism in the IMGSAC collection. Eur J Hum Genet 2009, 17:1347-1353.
47. Raymond F.L. X linked mental retardation: a clinical guide. J Med Genet 2006, 43:193-200.
48. Laumonnier F., Bonnet-Brilhault F., Gomot M., Blanc R., David A., Moizard M.P., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 2004, 74:552-557.
49. McCarthy S.E., Makarov V., Kirov G., Addington A.M., McClellan J., Yoon S., et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009, 41:1223-1227.
50. Lionel A.C., Crosbie J., Barbosa N., Goodale T., Thiruvahindrapuram B., Rickaby J., et al. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med 2011, 3:95ra75.
51. Rujescu D., Ingason A., Cichon S., Pietiläinen O.P., Barnes M.R., Toulopoulou T., et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 2009, 18:988-996.
52. Lindsay E.A., Morris M.A., Gos A., Nestadt G., Wolyniec P.S., Lasseter V.K., et al. Schizophrenia and chromosomal deletions within 22q11.2. Am J Hum Genet 1995, 56:1502-1503.
53. Miller D.T., Adam M.P., Aradhya S., Biesecker L.G., Brothman A.R., Carter N.P., et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010, 86:749-764.
54. Shen Y., Dies K.A., Holm I.A., Bridgemohan C., Sobeih M.M., Caronna E.B., et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 2010, 125:e727-e735.
55. Manning M., Hudgins L. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010, 12:742-745. Professional Practice and Guidelines Committee.
56. Duncan A., Chodirker B., Benoit L., Chakraborty P., Chodirker B., Duncan A.M.V., et al. CCMG position statement: use of array genomic hybridization technology in constitutional genetic diagnosis in Canada 2009, Canadian College of Medical Geneticists, Ontario, Canada, Avaliable at:, [accessed 25.06.12]. http://www.ccmg-ccgm.org/.
57. Baldwin E.L., Lee J.Y., Blake D.M., Bunke B.P., Alexander C.R., Kogan A.L., et al. Enhanced detection of clinically relevant genomic imbalances using a targeted plus whole genome oligonucleotide microarray. Genet Med 2008, 10:415-429.
58. Riggs E.R., Church D.M., Hanson K., Horner V.L., Kaminsky E.B., Kuhn R.M., et al. Towards an evidence-based process for the clinical interpretation of copy number variation. Clin Genet 2012, 81:403-412.
59. Firth H.V., Richards S.M., Bevan A.P., Clayton S., Corpas M., Rajan D., et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using ensembl resources. Am J Hum Genet 2009, 84:524-533.
60. Gurrieri F. Working up autism: the practical role of medical genetics. Am J Med Genet C Semin Med Genet 2012, 160C:104-110.
61. Johnson C.P., Myers S.M. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007, 120:1183-1215. American Academy of Pediatrics Council on Children With Disabilities.
62. Filipek P.A., Accardo P.J., Ashwal S., Baranek G.T., Cook E.H., Dawson G., et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 2000, 55:468-479.
63. Miles J.H., Takahashi T.N., Hong J., Munden N., Flournoy N., Braddock S.R., et al. Development and validation of a measure of dysmorphology: useful for autism subgroup classification. Am J Med Genet A 2008, 146A:1101-1116.
64. Lintas C., Persico A.M. Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist. J Med Genet 2009, 46:1-8.
65. Schaefer G.B., Lutz R.E. Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genet Med 2006, 8:549-556.
66. Schaefer G.B., Mendelsohn N.J. Genetics evaluation for the etiologic diagnosis of autism spectrum disorders. Genet Med 2008, 10:4-12.
67. Chung BHY, Cheuk DKL, Tang MHY, Lau E, Chan YK, Lau YL. Disclosing results of autism genomic testing-Systematic review and applying its results to clinical practice. In: Genetics and Genomics, May 17, 2012; Toronto, Canada: International Society for Autism Research; 2012. Abstract: 109.144.
68. Baret L., Godard B. Opinions and intentions of parents of an autistic child toward genetic research results: two typical profiles. Eur J Hum Genet 2011, 19:1127-1132.
69. Hayeems R.Z., Miller F.A., Li L., Bytautas J.P. Not so simple: a quasi-experimental study of how researchers adjudicate genetic research results. Eur J Hum Genet 2011, 19:740-747.
70. Miller F.A., Hayeems R.Z., Bytautas J.P. What is a meaningful result? Disclosing the results of genomic research in autism to research participants. Eur J Hum Genet 2010, 18:867-871.
71. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
72. Sanders S.J., Murtha M.T., Gupta A.R., Murdoch J.D., Raubeson M.J., Willsey A.J., et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
73. Neale B.M., Kou Y., Liu L., Ma'ayan A., Samocha K.E., Sabo A., et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485:242-245.
74. Singleton A.B. Exome sequencing: a transformative technology. Lancet Neurol 2011, 10:942-946.
75. Nguyen A., Rauch T.A., Pfeifer G.P., Hu V.W. Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J 2010, 24:3036-3051.
76. Shulha H.P., Cheung I., Whittle C., Wang J., Virgil D., Lin C.L., et al. Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons. Arch Gen Psychiatry 2012, 69:314-324.
77. Kaffman A., Krystal J.H. New frontiers in animal research of psychiatric illness. Methods Mol Biol 2012, 829:3-30.
78. Smith S.E., Zhou Y.D., Zhang G., Jin Z., Stoppel D.C., Anderson M.P. Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci Transl Med 2011, 3:103ra97.
79. Dölen G., Bear M.F. Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome. J Physiol 2008, 586:1503-1508.
80. Berry-Kravis E., Hessl D., Coffey S., Hervey C., Schneider A., Yuhas J., et al. A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet 2009, 46:266-271.
81. Siller S.S., Broadie K. Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome. Neural Plast 2012, 2012:124548.
82. Kim H.S., Suh Y.H. Minocycline and neurodegenerative diseases. Behav Brain Res 2009, 196:168-179.
83. Bilousova T.V., Dansie L., Ngo M., Aye J., Charles J.R., Ethell D.W., et al. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 2009, 46:94-102.
84. Utari A., Chonchaiya W., Rivera S.M., Schneider A., Hagerman R.J., Faradz S.M., et al. Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures. Am J Intellect Dev Disabil 2010, 115:433-443.